Sanofi Sponsored Breakfast Symposia - BR1DGE: From Autoimmunity to Action - Managing Early-stage Type 1 Diabetes

Tracks
Meeting Room 105 & 106
Thursday, August 20, 2026
7:00 AM - 8:00 AM
Meeting Room 106 (Level 1)

Details

"This 60-minute symposium will explore the evolving understanding of early-stage Type 1 Diabetes (T1D), focusing on screening, monitoring, and care pathways before clinical onset. This session is designed for the care teams involved in managing at-risk individuals. Learning objectives • Describe the current staging framework for early type 1 diabetes and its clinical relevance • Identify individuals at risk of progression who may benefit from structured monitoring • Apply staging and monitoring concepts to clinical decision-making


Speaker

Sarah Glastras

Welcome & Context

7:15 AM - 7:20 AM

Biography

Colin Dayan

B. T1D Evolution: Foundations to Current Understanding (15 min) – Prof Colin Dayan

7:20 AM - 7:35 AM

Biography

Agenda Item Image
Prof John Wentworth
Endocrinologist and Senior Clinical Researcher
Royal Melbourne Hospital / St Vincent's Institute of Medical Research

C. Redefining Early-Stage T1D: Monitoring & Intervention (15 min) – Prof John Wentworth

7:35 AM - 7:50 AM

Biography

Sarah Glastras

Expert Panel Discussion

7:50 AM - 8:10 AM

Biography

loading